The 'Full House' alum was speaking exclusively to PEOPLE at the 'Invisible Raptor' premiere on Wednesday, Dec. 4 ...

Over Ten Medical Institutions Nationwide have Initiated RenovoCath Purchase Process,Further Accelerating Commercialization ...

Theriva™ (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and ...

In a world flush with hazardous air pollutants, there is one that causes far more cancer than any other, one that is so ...

There's no routine screening test for pancreatic cancer, and symptoms can be mistaken for common illnesses.

WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news ...

The therapy, branded as Bizengri, targets the NRG1 gene, which is associated with formation and progression of several tumors ...

NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.

The therapy, branded as Bizengri, targets the NRG1 gene, which is associated with formation and progression of several tumors ...

The FDA has approved the first systemic therapy for patients with NSCLC or pancreatic adenocarcinoma with an NRG1 gene fusion.

The phase 3 PANOVA-3 trial, designed to evaluate concomitant treatment with tumor treating fields and chemotherapy, met its ...

Enrollment in cohort 5 of the phase 1/2 GOBLET study will resume after the Data Safety Monitoring Board’s safety review.